Clinuvel Pharmaceuticals Limited
CLVLF
$7.96
-$0.1583-1.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.75% | -42.06% | 0.21% | 127.91% | -0.47% |
| Total Depreciation and Amortization | -2.75% | 21.26% | 0.18% | -10.61% | -0.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.75% | 80.76% | -0.21% | -154.92% | -0.47% |
| Change in Net Operating Assets | -- | -- | -0.21% | -- | -- |
| Cash from Operations | -2.75% | 25.29% | 0.21% | -59.17% | -0.47% |
| Capital Expenditure | 2.58% | 78.56% | -0.22% | 94.77% | 0.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.75% | -138.86% | -0.21% | -20.08% | 0.47% |
| Cash from Investing | 2.75% | -134.27% | -0.21% | 17.95% | 0.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -2.19% | 0.00% | -11.45% | 0.00% |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Common Stock | 0.00% | 94.87% | 0.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.74% | -- | -- | 100.00% | 0.48% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.75% | -219.20% | -0.19% | 64.10% | 0.48% |
| Foreign Exchange rate Adjustments | -2.75% | 531.60% | -0.18% | 58.49% | 0.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.75% | -416.76% | -0.21% | -152.70% | -0.47% |